BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23468541)

  • 1. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
    De Marchis GM; Katan M; Weck A; Fluri F; Foerch C; Findling O; Schuetz P; Buhl D; El-Koussy M; Gensicke H; Seiler M; Morgenthaler N; Mattle HP; Mueller B; Christ-Crain M; Arnold M
    Neurology; 2013 Apr; 80(14):1278-86. PubMed ID: 23468541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke.
    Katan M; Fluri F; Morgenthaler NG; Schuetz P; Zweifel C; Bingisser R; Müller K; Meckel S; Gass A; Kappos L; Steck AJ; Engelter ST; Müller B; Christ-Crain M
    Ann Neurol; 2009 Dec; 66(6):799-808. PubMed ID: 20035506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma copeptin and long-term outcomes in acute ischemic stroke.
    Zhang JL; Yin CH; Zhang Y; Zhao LB; Fu HJ; Feng JC
    Acta Neurol Scand; 2013 Dec; 128(6):372-80. PubMed ID: 23614762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of copeptin: one-year outcome in patients with acute stroke.
    Urwyler SA; Schuetz P; Fluri F; Morgenthaler NG; Zweifel C; Bergmann A; Bingisser R; Kappos L; Steck A; Engelter S; Müller B; Christ-Crain M; Katan M
    Stroke; 2010 Jul; 41(7):1564-7. PubMed ID: 20508186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study.
    De Marchis GM; Katan M; Weck A; Brekenfeld C; Mattle HP; Buhl D; Müller B; Christ-Crain M; Arnold M
    Int J Stroke; 2013 Apr; 8(3):214-8. PubMed ID: 22336226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score.
    De Marchis GM; Dankowski T; König IR; Fladt J; Fluri F; Gensicke H; Foerch C; Findling O; Kurmann R; Fischer U; Luft A; Buhl D; Engelter ST; Lyrer PA; Christ-Crain M; Arnold M; Katan M
    Neurology; 2019 Mar; 92(13):e1517-e1525. PubMed ID: 30824558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
    De Marchis GM; Weck A; Audebert H; Benik S; Foerch C; Buhl D; Schuetz P; Jung S; Seiler M; Morgenthaler NG; Mattle HP; Mueller B; Christ-Crain M; Arnold M; Katan M
    Stroke; 2014 Oct; 45(10):2918-23. PubMed ID: 25169950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copeptin is associated with mortality in patients with traumatic brain injury.
    Dong XQ; Huang M; Yang SB; Yu WH; Zhang ZY
    J Trauma; 2011 Nov; 71(5):1194-8. PubMed ID: 21502880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of copeptin: one-year outcome in patients with traumatic brain injury.
    Yu GF; Huang Q; Dai WM; Jie YQ; Fan XF; Wu A; Lv Y; Li YP; Yan XJ
    Peptides; 2012 Jan; 33(1):164-9. PubMed ID: 22138140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copeptin is associated with one-year mortality and functional outcome in patients with acute spontaneous basal ganglia hemorrhage.
    Zhang X; Lu XM; Huang LF; Ye H
    Peptides; 2012 Feb; 33(2):336-41. PubMed ID: 22286033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma copeptin, a possible prognostic marker in cirrhosis.
    Moreno JP; Grandclement E; Monnet E; Clerc B; Agin A; Cervoni JP; Richou C; Vanlemmens C; Dritsas S; Dumoulin G; Di Martino V; Thevenot T
    Liver Int; 2013 Jul; 33(6):843-51. PubMed ID: 23560938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study.
    Narayan H; Dhillon OS; Quinn PA; Struck J; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2011 Jul; 121(2):79-89. PubMed ID: 21309746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.
    Katan M; Fluri F; Schuetz P; Morgenthaler NG; Zweifel C; Bingisser R; Kappos L; Steck A; Engelter ST; Müller B; Christ-Crain M
    J Am Coll Cardiol; 2010 Sep; 56(13):1045-53. PubMed ID: 20846604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of copeptin predict 1-year mortality in patients with acute ischemic stroke.
    Wang CW; Wang JL; Zhang Y; Li Q; Guo SX; Ji SB
    Neuroreport; 2014 Dec; 25(18):1447-52. PubMed ID: 25383462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASTRAL score predicts 5-year dependence and mortality in acute ischemic stroke.
    Papavasileiou V; Milionis H; Michel P; Makaritsis K; Vemmou A; Koroboki E; Manios E; Vemmos K; Ntaios G
    Stroke; 2013 Jun; 44(6):1616-20. PubMed ID: 23559264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
    Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K
    Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copeptin and high sensitive troponin for a rapid rule out of acute myocardial infarction?
    Giavarina D; Carta M; Fortunato A; Wratten ML; Hartmann O; Soffiati G
    Clin Lab; 2011; 57(9-10):725-30. PubMed ID: 22029188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score.
    Ntaios G; Faouzi M; Ferrari J; Lang W; Vemmos K; Michel P
    Neurology; 2012 Jun; 78(24):1916-22. PubMed ID: 22649218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in plasma copeptin level after acute spontaneous basal ganglia hemorrhage.
    Dong XQ; Huang M; Yu WH; Zhang ZY; Zhu Q; Che ZH; Du Q; Wang H
    Peptides; 2011 Feb; 32(2):253-7. PubMed ID: 21126545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
    Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
    Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.